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Ooguchi, Kouzou Ashida, Kouzou Fujio, Akinobu Takaki, Taiji Yonei, Toshimi
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Abstract
We report here a case of hepatocellular carcinoma (HCC) with multiple lung metastases,
which were disappeared by treatment of OK-432. The patient was a 65-year-old man and was
diagnosed in 1986 with a small (17 x 11 mm) HCC in the anterior-superior segment of the liver.
A part of the right hepatic lobe including the tumor was surgically removed, and transarterial in-
jections of adriamycin (10 mg/week) and subcutaneous injections of OK-432 (10 KE/week) were
given. Two and a half years later, recurrence of HCC in the liver and its invasion to vena cava
inferior (IVC) were found. OK-432 administration was then stopped and percutaneous ethanol
injection therapy (PEIT) was performed 10 times. Six months later, the PEIT was effective and
the liver tumor with IVC invasion diminished. However, multiple lung metastases were visible on
roentgenograms of the chest, and serum alphafetoprotein (AFP) concentration increased to 50,000
ng/ml. The OK-432 treatment resumed. After 6 months of OK-432 treatment, the multiple lung
metastases were disappeared and the serum AFP level decreased to 100 ng/ml. At present, the
patient is surviving without any sign of recurrence in either the liver or the lung. The clinical
course of this case suggests that OK-432 might have effectively treated lung metastases of HCC,
although the exact mechanisms are at present unclear.
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